Biotech Showcase inks pact with Astia to help women-led biotech companies

NewsGuard 100/100 Score

EBD Group and Demy-Colton Life Science Advisors, the producers of Biotech Showcase™, and Astia today announced a strategic collaboration designed to ensure that women-led biotech companies gain the investor and industry relationships needed to successfully grow their businesses. Under this agreement, Astia’s biotech clients participating in the Astia Silicon Valley Doing it Right Program will have the opportunity to present at the second annual Biotech Showcase 2010 held on January 12–13, 2010 at the Marines’ Memorial Club and Hotel, San Francisco, CA.

Astia is a global network of over 700 experts whose goal is to ensure the success of women in high-growth start-ups, primarily in high tech, clean tech and life science sectors. Co-produced by EBD Group and Demy-Colton Life Science Advisors, the Biotech Showcase is a forum providing private and public companies an opportunity to present to an audience of investors and biopharmaceutical business development executives.

“The Biotech Showcase has quickly established itself as a premier venue for companies to present their innovations to potential private and institutional investors and business development teams from pharmaceutical and large biotech firms,” said Sharon Vosmek, CEO, Astia. “Being featured at the Biotech Showcase has the potential to catapult a company several steps forward toward achieving its business goals, and this is why we view it as ‘the forum’ for the Astia companies to be showcased.”

Astia's Silicon Valley Doing it Right program provides unprecedented access to funding, markets and expertise resulting in an exceptional success rate for its clients. Since 2003, greater than 60 per cent of the companies who have presented at the Astia Investor Forums have achieved funding or an exit within one year. During this same period, 12 companies have exited, including two IPS, both in the biotech space.

Chris Meda, president and CEO of Astia supported company, Arcxis Biotechnologies, remarked, “As CEO of a biotech start up and an Astia alumna I am excited about the announcement of the partnership with Biotech Showcase – this will allow Astia entrepreneurs to benefit from the power of the Astia community while ensuring we are being showcased in one of the premier forums for our industry. Astia has always reached out for the best opportunities for its entrepreneurs and this is another illustration.”

“Astia is an organization we are excited to be working with,” said Carola Schropp, President, EBD Group. “By working with exceptional women entrepreneurs as they drive innovation and build successful biotech companies, Astia plays an important role in the long-term success of our bio-economy.”

“I am very excited about this opportunity to work with Astia. Building a successful life science company takes great science, access to capital and, above all, a great management team. We are very impressed with the community that Astia offers up and coming management teams and the fact that advisors are there for the long-term,” said Sara Jane Demy, President of Demy-Colton Life Science Advisors.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sympathetic nervous system and immune interplay: Key to metabolic regulation